SCHEMBL7083205

SCHEMBL7083205

CCCCC(=O)NS(=O)(=O)c1ccccc1NC(=O)c1cccc(OCc2ccccc2)c1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.52
TSHR P16473 2/20 0.52
GAA P10253 1/20 0.52
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
SMPD1 P17405 3/20 0.50
NR1H4 Q96RI1 2/20 0.50
HDAC1 Q13547 1/20 0.50
HDAC8 Q9BY41 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
KAT6A Q92794 2/20 0.49
AKR1C2 P52895 1/20 0.47
AKR1C1 Q04828 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
BCL2L1 Q07817 1/20 0.47
MCL1 Q07820 1/20 0.47
MAOB P27338 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7050498 0.97 SMPD1 (0.52) ALDH1A1TSHRGAAMEN1KMT2A
SCHEMBL7077178 0.96 SMPD1 (0.53) ALDH1A1TSHRGAAMEN1KMT2A
SCHEMBL7047657 0.96 SMPD1 (0.53) ALDH1A1TSHRGAAMEN1KMT2A
SCHEMBL7083526 0.96 SMPD1 (0.53) ALDH1A1TSHRGAAMEN1KMT2A
SCHEMBL7076275 0.96 SMPD1 (0.53) ALDH1A1TSHRGAAMEN1KMT2A
SCHEMBL7077945 0.96 SMPD1 (0.53) ALDH1A1TSHRGAAMEN1KMT2A
SCHEMBL7080208 0.96 SMPD1 (0.53) ALDH1A1TSHRGAAMEN1KMT2A
SCHEMBL7076746 0.96 SMPD1 (0.53) ALDH1A1TSHRGAAMEN1KMT2A
SCHEMBL7080258 0.96 SMPD1 (0.53) ALDH1A1TSHRGAAMEN1KMT2A
SCHEMBL7080217 0.96 SMPD1 (0.53) ALDH1A1TSHRGAAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030162818-A1 Acylsulfonamide derivative AJINOMOTO CO. INC. (JP) 2003-08-28 US disclosed
US-6555584-B1 Acetyl-coa carboxylase inhibitors AJINOMOTO CO., INC. (JP) 2003-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162818-A1 Acylsulfonamide derivative ACSS2, ACACA, FASN ALDH1A1 385/4885TSHR 2829/4885GAA 761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.